VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $13,000 | -87.0% | 550 | -91.3% | 0.01% | -82.8% |
| Q1 2018 | $100,000 | -23.7% | 6,300 | 0.0% | 0.03% | -23.7% |
| Q4 2017 | $131,000 | +107.9% | 6,300 | +43.2% | 0.04% | +81.0% |
| Q3 2017 | $63,000 | -8.7% | 4,400 | +10.0% | 0.02% | -16.0% |
| Q2 2017 | $69,000 | +50.0% | 4,000 | +1042.9% | 0.02% | +8.7% |
| Q3 2014 | $46,000 | +4.5% | 350 | 0.0% | 0.02% | +9.5% |
| Q2 2014 | $44,000 | -4.3% | 350 | 0.0% | 0.02% | +40.0% |
| Q1 2014 | $46,000 | – | 350 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |